Skip to content

DOMAIN ASSOCIATES, LLC

DOMAIN ASSOCIATES, LLC is a Pre-seed, Seed, Series A, Series B, Series C+ and ipo fund in the US writing $5M–$20M checks into biotechnology, therapeutics, diagnostics, medical-devices, pharmaceuticals and drug-discovery.

Stages
Pre-seed, Seed, Series A, Series B, Series C+, ipo
Sectors
biotechnology, therapeutics, diagnostics, medical-devices, pharmaceuticals, drug-discovery
Check size
$5M–$20M
Invests in
US-wide
Actively investing
Yes
Founded
1985
Assets under management
$2.8B

Thesis

Domain Associates, LLC is a venture capital firm established in 1985, specializing in the life sciences sector, with a strong emphasis on biotechnology, pharmaceuticals, medical devices, and diagnostics. The firm's investment thesis centers on therapeutics, diagnostics, and medical devices, engaging with companies from pre-seed and seed stages through Series A, B, C, and growth equity, up to IPOs. They also participate in company creation. While specific check sizes are not disclosed, typical investments range from $5 million to $20 million. Geographically, Domain Associates is primarily a U.S.-centric investor, focusing on the North American market, but may consider global biotechnology opportunities. The firm has reported AUM figures varying between $2.8 billion and less than $150 million, operating multiple private funds. The firm boasts a strong track record with 90 IPOs and over 110 M&A transactions. Their headquarters are in Princeton, New Jersey, with an additional office in San Diego, California.

Common questions

Does DOMAIN ASSOCIATES, LLC invest at the Pre-seed stage?

Yes. DOMAIN ASSOCIATES, LLC lists Pre-seed, Seed, Series A, Series B, Series C+ and ipo among the stages it invests in.

What check size does DOMAIN ASSOCIATES, LLC write?

DOMAIN ASSOCIATES, LLC writes $5M–$20M checks.

Where does DOMAIN ASSOCIATES, LLC invest?

DOMAIN ASSOCIATES, LLC invests in the US.